None listed
Conditions
Interventions
None listed
Sponsors
Gyeongsang National University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: -. Patients older than 40 years of age -. Diagnosed with Chronic obstructive pulmonary disease -. Agree with Participating Research -. Treated by MITT(Multiple Inhaler Triple Treatment),(>=90days)
Exclusion criteria
Exclusion criteria: - a potentially pregnant patient - Patients who are likely to die within 6 months or have poor health. - Patients with unstable COPD with exacerbation within 4 weeks. - Patients with other illnesses or mental illnesses. - Patients who are hypersensitive to steroids and anti-choline, muscarinic drugs, and lactose/lactose proteins. - Patients who use oral steroids for a long period of time (over 4 weeks) due to diseases other than COPD. - Patients currently participating in interventional clinical research.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change from baseline of CAT Score | — |
Secondary
| Measure | Time frame |
|---|---|
| Change from baseline of FEV1;Over 2 point improved from baseline of CAT Score;Comparison of CAT Score improvements of more than 2 points for patients using the Elipta Device compared to patients who did not use the previous Elipta Device;Comparison of FEV1 improvements for patients using the Elipta Device compared to patients who did not use the previous Elipta Device; Clinically Important Deterioration (FEV1, Exacerbation, CAT);Comparison of FEV1 improvements for patients using the Elipta Device compared to patients who did not use the previous Elipta Device;Change from Baseline of mMRC;Over 1point improvement of baseline on mMRC;Change from baseline of TS-VAS;Exacerbation rate in 1 year | — |
Countries
Korea, Republic of
Contacts
Public ContactLim hana
Sungkyunkwan University
Outcome results
None listed